Immunocontraceptive approaches in females

Chemical Immunology and Allergy

Volumn 88, Issue , 2005, Pages 98-108

  Gupta, Satish Kumar ^a   Chakravarty, Sanchita ^a   Kadunganattil, Suraj ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT; DNA VACCINE; EPITOPE; FOLLITROPIN; GLYCOPROTEIN; GONADORELIN; IMMUNOGLOBULIN G ANTIBODY; LUTEINIZING HORMONE; RECOMBINANT PROTEIN; SPERM ANTIGEN; TETANUS ANTIBODY; UNCLASSIFIED DRUG; ZONA PELLUCIDA GLYCOPROTEIN; ZONA PELLUCIDA GLYCOPROTEIN A; ZONA PELLUCIDA GLYCOPROTEIN B; ZONA PELLUCIDA GLYCOPROTEIN C;

ACTIVE IMMUNIZATION; ANTIBODY TITER; ANTIGEN SPECIFICITY; CLINICAL TRIAL; FEMALE INFERTILITY; FERTILITY; FERTILIZATION; GAMETOGENESIS; HUMAN; IMMUNIZATION; IMMUNOCONTRACEPTION; IMMUNOGENICITY; NONHUMAN; OVARY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ZONA PELLUCIDA;

EID: 30744433613     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000087823     Document Type: Review

References (48)

1. Hodges JK, Hearn JP: Effects of immunization against luteinizing hormone releasing hormone on reproduction of the marmoset monkey Callithrix jacchus. Nature 1977;265:746-748.
2. Takahashi M, Ford JJ, Yoshinaga K, Greep RO: Active immunization of female rats with luteinizing hormone releasing hormone (LHRH). Biol Reprod 1978;18:754-761.
3. Talwar GP, Gupta SK, Singh V, Sahal D, Iyer KS, Singh O: Bioeffective monoclonal antibody against the decapeptide gonadotropin-releasing hormone: Reacting determinant and action on ovulation and estrus suppression. Proc Natl Acad Sci USA 1985;82:1228-1231.
4. Miller LA, Johns BE, Killian GJ: Immunocontraception of white-tailed deer with GnRH vaccine. Am J Reprod Immunol 2000;44:266-274.
5. Oonk HB, Turkstra JA, Schaaper WM, Erkens JH, Schuitemaker-de Weerd MH, van Nes A, Verheijden JH, Meloen RH: New GnRH-like peptide construct to optimize efficient immunocastration of male pigs by immunoneutralization of GnRH. Vaccine 1998;16:1074-1082.
6. Ingerslev HJ: Antibodies against spermatozoal surface-membrane antigens in female infertility. Acta Obstet Gynecol Scand Suppl 1981;100:1-52.
7. Gwatkin RB, Williams DT, Carlo DJ: Immunization of mice with heat solubilized hamster zonae: Production of anti-zona antibody and inhibition of fertility. Fertil Steril 1977;28:871-877.
8. Wood DM, Liu C, Dunbar BS: Effect of alloimmunization and heteroimmunization with zonae pellucidae on fertility in rabbits. Biol Reprod 1981;25:439-450.
9. Gulyas BJ, Yuan LC, Gwatkin RB, Schmell ED: Response of monkeys to porcine zona pellucida as detected by a solid-phase radioimmunoassay. J Med Primatol 1983;12:331-342.
10. Sacco AG, Pierce DL, Subramanian MG, Yurewicz EC, Dukelow WR: Ovaries remain functional in squirrel monkeys (Saimiri sciureus) immunized with porcine zona pellucida 55,000 macromolecule. Biol Reprod 1987;36:481-490.
11. Bagavant H, Thillai-Koothan P, Sharma MG, Talwar GP, Gupta SK: Antifertility effects of porcine zona pellucida-3 immunization using permissible adjuvants in female bonnet monkeys (Macaco radiata): Reversibility, effect on follicular development and hormonal profiles. J Reprod Fertil 1994;102:17-25.
12. Paterson M, Wilson MR, Morris KD, van Duin M, Aitken RJ: Evaluation of the contraceptive potential of recombinant human ZP3 and human ZP3 peptides in a primate model: Their safety and efficacy. Am J Reprod Immunol 1998;40:198-209.
13. Martinez ML, Harris JD: Effectiveness of zona pellucida protein ZPB as an immunocontraceptive antigen. J Reprod Fertil 2000;120:19-32.
14. Govind CK, Gupta SK: Failure of female baboons (Papio anubis) to conceive following immunization with recombinant non-human primate zona pellucida glycoprotein-B expressed in Escherichia coli. Vaccine 2000;18:2970-2978.
15. Govind CK, Srivastava N, Gupta SK: Evaluation of the immunocontaceptive potential of Escherichia coli expressed recombinant non-human primate zona pellucida glycoproteins in homologous animal model. Vaccine 2002;21:78-88.
16. Zhang X, Lou YH, Koopman M, Doggett T, Tung KS, Curtiss R 3rd: Antibody responses and infertility in mice following oral immunization with attenuated Salmonella typhimurium expressing recombinant murine ZP3. Biol Reprod 1997;56:33-41.
17. Jackson RJ, Maguire DJ, Hinds LA, Ramshaw IA: Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3. Biol Reprod 1998;58:152-159.
18. Lloyd ML, Shellam GR, Papadimitriou JM, Lawson MA: Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3. Biol Reprod 2003;68:2024-2032.
19. Leitner WW, Ying H, Restifo NP: DNA and RNA based vaccines: Principles, progress and prospects. Vaccine 1999;18:765-777.
20. Rath A, Choudhury S, Hasegawa A, Koyama K, Gupta SK: Antibodies generated in response to plasmid DNA encoding zona pellucida glycoprotein-B inhibit in vitro human sperm-egg binding. Mol Reprod Dev 2002;62:525-533.
21. Rath A, Batra D, Kaur R, Vrati S, Gupta SK: Characterization of immune response in mice to plasmid DNA encoding dog zona pellucida glycoprotein-3. Vaccine 2003;21:1913-1923.
22. Xiang RL, Zhou F, Yang Y, Peng JP: Construction of the plasmid pCMV4-rZPC' DNA vaccine and analysis of its contraceptive potential. Biol Reprod 2003;68:1518-1524.
23. Lou AM, Garza KM, Hunt D, Tung KS: Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest 1993;92:2117-2123.
24. Sivapurapu N, Upadhyay A, Hasegawa A, Koyama K, Gupta SK: Native zona pellucida reactivity and in vitro effect on human sperm-egg binding with antisera against bonnet monkey ZP1 and ZP3 synthetic peptides. J Reprod Immunol 2002;56:77-91.
25. Bagavant H, Fusi FM, Baisch J, Kurth B, David CS, Tung KS: Immunogenicity and contraceptive potential of a human zona pellucida 3 peptide vaccine. Biol Reprod 1997;56:764-770.
26. Hinsch E, Hagele W, Bohle RM, Schill WB, Hinsch KD: Evaluation of ZP2 domains of functional importance with antisera against synthetic ZP2 peptides. J Reprod Fertil 1998;114:245-251.
27. Hasegawa A, Hamada Y, Shigeta M, Koyama K: Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA). J Reprod Immunol 2002;53:91-98.
28. Sun W, Lou YH, Dean J, Tung KS: A contraceptive peptide vaccine targeting sulfated glycoprotein ZP2 of the mouse zona pellucida. Biol Reprod 1999;60:900-907.
29. Lou Y, Ang J, Thai H, McElveen F, Tung KS: A zona pellucida 3 peptide vaccine induces antibodies and reversible infertility without ovarian pathology. J Immunol 1995;155:2715-2720.
30. Paterson M, Wilson MR, Jennings ZA, van Duin M, Aitkin RJ: Design and evaluation of a ZP3 peptide vaccine in a homologous primate model. Mol Hum Reprod 1999;5:342-352.
31. Kaul R, Sivapurapu N, Afzalpurkar A, Srikanth V, Govind CK, Gupta SK: Immunocontraceptive potential of recombinant bonnet monkey (Macaca radiata) zona pellucida glycoprotein-C expressed in Escherichia coli and its corresponding synthetic peptide. Reprod Biomed Online 2001;2:33-39.
32. Afzalpurkar A, Shibahara H, Hasegawa A, Koyama K, Gupta SK: Immunoreactivity and in vitro effect on human sperm-egg binding of antibodies against peptides corresponding to bonnet monkey zona pellucida-3 glycoprotein. Hum Reprod 1997;12:2664-2670.
33. Sivapurapu N, Upadhyay A, Hasegawa A, Koyama K, Gupta SK: Efficacy of antibodies against Escherichia coli expressed chimeric recombinant protein encompassing multiple epitopes of zona pellucida glycoproteins to inhibit in vitro human sperm-egg binding. Mol Reprod Dev 2003;65:309-317.
34. Lea IA, Widgren EE, O'Rand MG: Analysis of recombinant mouse zona pellucida protein-2 (ZP-2) constructs for immunocontraception. Vaccine 2002;20:1515-1523.
35. Talwar GP, Sharma NC, Dubey SK, Salahuddin M, Das C, Ramakrishnan S, Kumar S, Hingorani V: Isoimmunization against human chorionic gonadotropin with conjugates of processed β-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci USA 1976;73:218-222.
36. Nash H, Johansson ED, Talwar GP, Vasquez J, Segal S, Coutinho E, Lukkainen T, Sundaram K: Observations on the antigenicity and clinical effects of a candidate anti-pregnancy vaccine: β-Subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril 1980; 34:328-335.
37. Talwar GP, Singli O, Pal R, Chatterjee N, Sahai P, Dhall K, Kaur J, Das SK, Suri S, Buckshee K, Saraya L, Saxena BB: A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA 1994;91:8532-8536.
38. Stevens VC: Development of a vaccine against human chorionic gonadotropin using a synthetic peptide as the immunogen; in Clark DA, Croy BA (eds): Reproductive Immunology - 1986. Amsterdam, Elsevier Science, 1986, pp 162-169.
39. Stevens VC: Antifertility vaccines; in Perlmann P, Wigzell H (eds): Handbook of Experimental Pharmacology. New York, Springer, 1999, pp 443-446.
40. Ehrlich PH, Bernard MP, Myers RV, Macdonald GJ, Moyle WR: Epitope-specific focusing of the immune response to a minimized human chorionic gonadotropin analog. Biochem Biophys Res Commun 1998;247:315-318.
41. Chiesa MD, Martensen PM, Simmons C, Porakishvili N, Justesen J, Dougan G, Roitt IM, Delves PJ, Lund T: Refocusing of B-cell responses following a single amino acid substitution in an antigen. Immunology 2001;103:172-178.
42. Porakishvili N, Chiesa MD, Chikadze N, Martensen P, Justesen J, Lund T, Delves PJ, Roitt IM: Elimination of luteinizing hormone cross-reactive epitopes from human chorionic gonadotropin. Vaccine 2002;20:2053-2059.
43. Zhao XR, Li DJ, Yuan MM, Cai LR, Sun XX: C3d molecular adjuvant increases the immunity of human chorionic gonadotropin beta DNA contraceptive vaccination and changes its immune response from Th1 to Th2. Zhonghua Yi Xue Za Zhi 2003;83:1906-1909.
44. Adiga PR, Subramanian S, Rao J, Kumar M: Prospects of riboflavin carrier protein (RCP) as an antifertility vaccine in male and female mammals. Hum Reprod Update 1997;3:325-334.
45. Subramanian S, Karande AA, Adiga PR: Immunocontraceptive potential of major antigenic determinants of chicken riboflavin carrier protein in the female rat. Vaccine 2000;19:1172-1179.
46. Kirkpatrick JF, Turner JW Jr, Liu IK, Fayrer-Hosken R: Applications of pig zona pellucida immunocontraception to wildlife fertility control. J Reprod Fertil Suppl 1996;50:183-189.
47. Brown RG, Bowen WD, Eddington JD, Kimmins WC, Mezei M, Parsons JL, Pohajdak B: Evidence for a long-lasting single administration contraceptive vaccine in grey seals. J Reprod Immunol 1997;35:43-51.
48. Srivastava N, Santhanam R, Sheela P, Mukund S, Thakral SS, Malik BS, Gupta SK: Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model. Reproduction 2002;123:847-857.